IL131160A0 - 5-Aminoalkoxy-1,4-dihydroquinoxaline-2,3-diones being dopamine agonists - Google Patents
5-Aminoalkoxy-1,4-dihydroquinoxaline-2,3-diones being dopamine agonistsInfo
- Publication number
- IL131160A0 IL131160A0 IL13116098A IL13116098A IL131160A0 IL 131160 A0 IL131160 A0 IL 131160A0 IL 13116098 A IL13116098 A IL 13116098A IL 13116098 A IL13116098 A IL 13116098A IL 131160 A0 IL131160 A0 IL 131160A0
- Authority
- IL
- Israel
- Prior art keywords
- dihydroquinoxaline
- aminoalkoxy
- diones
- dopamine agonists
- dopamine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80132497A | 1997-02-18 | 1997-02-18 | |
| PCT/US1998/001170 WO1998035948A1 (en) | 1997-02-18 | 1998-01-13 | 5-aminoalkoxy-1,4-dihydroquinoxaline-2,3-diones being dopamine agonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL131160A0 true IL131160A0 (en) | 2001-01-28 |
Family
ID=25180799
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13116098A IL131160A0 (en) | 1997-02-18 | 1998-01-13 | 5-Aminoalkoxy-1,4-dihydroquinoxaline-2,3-diones being dopamine agonists |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0963372A1 (de) |
| JP (1) | JP2001511805A (de) |
| KR (1) | KR20000071162A (de) |
| CN (1) | CN1248249A (de) |
| AR (1) | AR011669A1 (de) |
| AU (1) | AU722616B2 (de) |
| BR (1) | BR9807230A (de) |
| CA (1) | CA2278757A1 (de) |
| HU (1) | HUP0001311A3 (de) |
| IL (1) | IL131160A0 (de) |
| NZ (1) | NZ336971A (de) |
| TW (1) | TW434230B (de) |
| WO (1) | WO1998035948A1 (de) |
| ZA (1) | ZA981306B (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2285786B1 (de) | 2008-06-16 | 2013-10-09 | Merck Patent GmbH | Chinoxalindionderivate |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO179551C (no) * | 1987-11-10 | 1996-10-30 | Novo Nordisk As | Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoxalinforbindelser |
| DK715888D0 (da) * | 1988-12-22 | 1988-12-22 | Ferrosan As | Quinoxalinforbindelser, deres fremstilling og anvendelse |
| US4975430A (en) * | 1989-06-16 | 1990-12-04 | The State Of Oregon Acting By And Through The State Board Of Education On Behalf Of The Oregon Health Sciences University | CNQX and its analogs as therapeutics for degenerative neural diseases |
| PT99864B (pt) * | 1990-12-21 | 1999-06-30 | Schering Ag | Processo para a preparacao de novas composicoes farmaceuticas contendo antagonistas de receptor de quisqualato |
| US5159083A (en) * | 1990-12-28 | 1992-10-27 | Neurogen Corporation | Certain aminomethyl phenylimidazole derivatives; a class of dopamine receptor subtype specific ligands |
| AU672617B2 (en) * | 1992-06-22 | 1996-10-10 | Regents Of The University Of California, The | Glycine receptor antagonists and the use thereof |
| GB9419318D0 (en) * | 1994-09-24 | 1994-11-09 | Pfizer Ltd | Therapeutic agents |
| SI0707007T1 (en) * | 1994-10-14 | 2002-04-30 | Merck Patent Gmbh | (R)-(-)-2-(5-(4-fluorophenyl)-3-pyridylmethylaminomethyl)chromane as CNS active agent |
| ZA9610745B (en) * | 1995-12-22 | 1997-06-24 | Warner Lambert Co | 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
-
1998
- 1998-01-13 BR BR9807230-7A patent/BR9807230A/pt not_active Application Discontinuation
- 1998-01-13 EP EP98903628A patent/EP0963372A1/de not_active Withdrawn
- 1998-01-13 JP JP53574298A patent/JP2001511805A/ja active Pending
- 1998-01-13 WO PCT/US1998/001170 patent/WO1998035948A1/en not_active Application Discontinuation
- 1998-01-13 NZ NZ336971A patent/NZ336971A/xx unknown
- 1998-01-13 AU AU60350/98A patent/AU722616B2/en not_active Ceased
- 1998-01-13 HU HU0001311A patent/HUP0001311A3/hu unknown
- 1998-01-13 KR KR1019997007452A patent/KR20000071162A/ko not_active Application Discontinuation
- 1998-01-13 IL IL13116098A patent/IL131160A0/xx unknown
- 1998-01-13 CA CA002278757A patent/CA2278757A1/en not_active Abandoned
- 1998-01-13 CN CN98802636A patent/CN1248249A/zh active Pending
- 1998-02-05 TW TW087101493A patent/TW434230B/zh active
- 1998-02-11 AR ARP980100618A patent/AR011669A1/es unknown
- 1998-02-17 ZA ZA9801306A patent/ZA981306B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR9807230A (pt) | 2000-04-25 |
| CN1248249A (zh) | 2000-03-22 |
| KR20000071162A (ko) | 2000-11-25 |
| ZA981306B (en) | 1999-08-17 |
| HUP0001311A2 (hu) | 2001-05-28 |
| EP0963372A1 (de) | 1999-12-15 |
| AR011669A1 (es) | 2000-08-30 |
| AU722616B2 (en) | 2000-08-10 |
| AU6035098A (en) | 1998-09-08 |
| JP2001511805A (ja) | 2001-08-14 |
| HUP0001311A3 (en) | 2001-07-30 |
| WO1998035948A1 (en) | 1998-08-20 |
| TW434230B (en) | 2001-05-16 |
| NZ336971A (en) | 2000-10-27 |
| CA2278757A1 (en) | 1998-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA989230B (en) | Prostaglandin agonists. | |
| ZA200100900B (en) | 2-substituted-1-piperidyl benzimidazole compounds as orl1-receptor agonists. | |
| ZA986784B (en) | Tricyclic vasopressin agonists. | |
| ZA9811959B (en) | Ibuprofen composition. | |
| DE59812367D1 (en) | 2-arylcyclopentan-1,3-dione | |
| ZA200203450B (en) | beta2-adrenergic receptor agonists. | |
| ZA987057B (en) | 2-benzoylcyclohexane-1,3-diones. | |
| ZA991272B (en) | Novel thiobenzamides. | |
| PL328505A1 (en) | 2-heteroaroylcyclohexano-1,3-diones | |
| ZA9811026B (en) | Selective B3 adrenergic agonists. | |
| ZA987056B (en) | 2-benzoylcyclohexane-1,3-diones. | |
| ZA988B (en) | 3-aminocarbonyl-/3-aminothiocarbonyl-substituted 2-benzoylcyclohexane-1,3-diones. | |
| ZA992899B (en) | Novel compound. | |
| PL334473A1 (en) | Substituted 2-benzoylcyclohexano-1,3-diones | |
| ZA996913B (en) | Tetrahydronaphthalenes. | |
| IL131160A0 (en) | 5-Aminoalkoxy-1,4-dihydroquinoxaline-2,3-diones being dopamine agonists | |
| ZA991893B (en) | 5-Heteroaryl substituted indoles. | |
| ZA995029B (en) | Estrogen agonists/antagonists. | |
| GB9810998D0 (en) | Antitumour 1,5-diazaanthraquinones | |
| PL336807A1 (en) | Substituted 2-(3-alkenylbenzoyl)cyclohexane-1,3-diones | |
| ZA981310B (en) | 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-one dopamine autoreceptor agonists. | |
| PL336794A1 (en) | Substituted 2-benzoylcyclohexane-1,3-diones | |
| AU4263999A (en) | Substituted 1,3-diaza-2-(thi)oxo-cycloalkanes | |
| ZA991761B (en) | New agent. | |
| ZA991492B (en) | Label holder. |